Back to top
more

Advanced Accelerator Applications S.A. (AAAP)

(Delayed Data from NSDQ)

$81.63 USD

81.63
NA

+0.13 (0.16%)

Updated Feb 9, 2018 04:00 PM ET

After-Market: $81.57 -0.06 (-0.07%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Deere (DE) to Report Q4 Earnings: What's in the Offing?

Deere's (DE) Q4 results will gain from improving economic and political conditions in Brazil despite weakness in livestock sector and the lingering impact of low crop prices.

    Valeant Pharmaceuticals (VRX) in Focus: Stock Moves 5.5% Higher

    Valeant Pharmaceuticals International (VRX) was a big mover last session, as the company saw its shares nearly 6% on the day amid huge volumes.

      Novartis Buys French Radiopharmaceutical Company

      Novartis (NVS) plans to acquire France-based Advanced Accelerator Applications. The takeover will add RadioLigand Therapy, Lutathera, in its portfolio with potential to drive growth in the near term.

        Advanced Accelerator (AAAP) in Focus: Stock Moves 10.4% Higher

        Advanced Accelerator (AAAP) was a big mover last session, as the company saw its shares more than 10% on the day amid huge volumes.

          Advanced Accelerator (AAAP) Cancer Therapy Approved in EU

          Advanced Accelerator Applications' (AAAP) Lutathera gets approval in Europe as its first radionuclide therapy for the treatment of tumors in the gut.

            Advanced Accelerator Applications (AAAP) in Focus: Stock Moves 7.5% Higher

            Advanced Accelerator Applications S.A. (AAAP) was a big mover last session, as the company saw its shares rise nearly 8% on the day.

              Advanced Accelerator Gets Action Date for Lutathera from FDA

              The FDA granted an action date for Lutathera after the company resubmitted the New Drug Application (NDA) for the candidate.

                Zacks.com featured highlights: Columbus McKinnon, The New York Times, Advanced Accelerator Applications, Enanta Pharmaceuticals and Caesars Entertainment

                Zacks.com featured highlights: Columbus McKinnon, The New York Times, Advanced Accelerator Applications, Enanta Pharmaceuticals and Caesars Entertainment

                  Buy These 5 Stocks on New Analyst Coverage

                  Increased analyst coverage over the last few weeks might translate into solid price appreciation for these stocks.

                    Advanced Accelerator Applications (AAAP) Rises: Stock Up 6.2%

                    Advanced Accelerator Applications S.A. (AAAP) shares rose a little above 6% in the last trading session.

                      Galmed Pharmaceuticals (GLMD) Catches Eye: Stock Gains 15.7%

                      Galmed Pharmaceuticals Ltd. (GLMD) shares jumped nearly 16% in the last trading session.

                        David Bartosiak headshot

                        Today's Strong Buys Breaking Out to New Highs

                        Another video diary of today's price action to go along with strong buys breaking out to new highs

                          Calithera Biosciences (CALA) Rises: Stock Moves Up 19.3%

                          Calithera Biosciences, Inc. (CALA) shares rose over 19% in the last trading session.

                            Acadia Healthcare (ACHC) Tops Q4 Earnings, Gives 2017 View

                            Acadia Healthcare Company Inc. (ACHC) reported fourth-quarter 2016 adjusted earnings of 59 cents per share, which surpassed the Zacks Consensus Estimate by 4 cents.

                              Advanced Accelerator (AAAP) Catches Eye: Stock Jumps 5.4%

                              Advanced Accelerator Applications S.A. (AAAP) moved big last session, as its shares rose over 5% on the day.